Evaluation of the effect of a single intake of protein hydrolysate on metabolic indices in blood
- Conditions
- Healthy adult male and female
- Registration Number
- JPRN-UMIN000046829
- Lead Sponsor
- SOUKEN Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Subjects who have been diagnosed with or are undergoing treatment for mood disorders such as depression 2) Subjects who regularly use health foods such as supplements that claim to have effects on stress and mental health. 3) Subjects who consume a large amount of milk, dairy products, or milk-derived protein every day. 4) Subjects who have a habit of doing strenuous exercise. 5) Subjects who have an irregular life cycle 6) Subjects who may change their lifestyle such as a long trip, etc. 7) Subjects with gastrointestinal weakness, history of gastrointestinal problems, or current illness. 8) Subjects who drink a lot of alcohol. 9) Subjects who have a smoking habit. 10) Subjects who participated in a study involving the use other foods or medicines, or the application of cosmetics or medicines within one month prior to obtaining consent, or who will participate in another study while participating in this study. 11) Subjects who have donated 200 mL or more of blood (including whole blood and components) for 4 months before the start of the study. 12) Subjects who have experienced bad feeling or poor in physical condition due to blood collection in the past. 13) Subjects who may exhibit symptoms of allergy to milk or soy, or those who have a lactose intolerant constitution. 14) Subjects who are pregnant, or breast-feeding, or who planning to be pregnant during the study period. 15) Subjects with a history of serious hepatic, renal, or cardiac disease. 16) Subjects with a history or current illness of hepatitis, or severe anemia. 17) Subjects who are currently undergoing regular hospital visits and treatment for any kind of illness. 18) Subjects who are judged as unsuitable for the study because of the menstrual disorders or etc. by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma metabolism-related biomarkers
- Secondary Outcome Measures
Name Time Method Fatigue-related questionnaire